IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.
about
Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang CytokineB cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33The Role of IL-33/ST2 Pathway in Tumorigenesis
P2860
IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
IL-33 blockade suppresses tumo ...... thways in a preclinical model.
@en
type
label
IL-33 blockade suppresses tumo ...... thways in a preclinical model.
@en
prefLabel
IL-33 blockade suppresses tumo ...... thways in a preclinical model.
@en
P2093
P2860
P356
P1433
P1476
IL-33 blockade suppresses tumo ...... thways in a preclinical model.
@en
P2093
Chunhong Wang
Kailing Wang
Yuanyuan Wang
Zongjun Yang
P2860
P304
68571-68582
P356
10.18632/ONCOTARGET.19786
P407
P577
2017-08-02T00:00:00Z